510 related articles for article (PubMed ID: 9817302)
1. Cytokeratin 20: a new marker for early detection of bladder cell carcinoma?
Buchumensky V; Klein A; Zemer R; Kessler OJ; Zimlichman S; Nissenkorn I
J Urol; 1998 Dec; 160(6 Pt 1):1971-4. PubMed ID: 9817302
[TBL] [Abstract][Full Text] [Related]
2. Expression of cytokeratin 20 in urinary cytology of patients with bladder carcinoma.
Klein A; Zemer R; Buchumensky V; Klaper R; Nissenkorn I
Cancer; 1998 Jan; 82(2):349-54. PubMed ID: 9445193
[TBL] [Abstract][Full Text] [Related]
3. Quantitative detection of cytokeratin 20 mRNA expression in bladder carcinoma by real-time reverse transcriptase-polymerase chain reaction.
Christoph F; Müller M; Schostak M; Soong R; Tabiti K; Miller K
Urology; 2004 Jul; 64(1):157-61. PubMed ID: 15245962
[TBL] [Abstract][Full Text] [Related]
4. Detection of hematogenous micrometastasis in patients with transitional cell carcinoma.
Güdemann CJ; Weitz J; Kienle P; Lacroix J; Wiesel MJ; Soder M; Benner A; Staehler G; Doeberitz MV
J Urol; 2000 Aug; 164(2):532-6. PubMed ID: 10893639
[TBL] [Abstract][Full Text] [Related]
5. Urinary cytokeratin 20 as a marker for transitional cell carcinoma.
Rotem D; Cassel A; Lindenfeld N; Mecz Y; Sova Y; Resnick M; Stein A
Eur Urol; 2000 May; 37(5):601-4. PubMed ID: 10765100
[TBL] [Abstract][Full Text] [Related]
6. Value of reverse transcription polymerase chain assay in peripheral blood of patients with urothelial cancer.
Okegawa T; Kinjo M; Nutahara K; Higashihara E
J Urol; 2004 Apr; 171(4):1461-6. PubMed ID: 15017198
[TBL] [Abstract][Full Text] [Related]
7. Real time reverse transcriptase polymerase chain reaction of urinary cytokeratin 20 detects transitional cell carcinoma cells.
Inoue T; Nakanishi H; Inada K; Hioki T; Tatematsu M; Sugimura Y
J Urol; 2001 Dec; 166(6):2134-41. PubMed ID: 11696722
[TBL] [Abstract][Full Text] [Related]
8. Detection of mucin 7 gene expression in exfoliated cells in urine from patients with bladder tumor.
Okegawa T; Kinjo M; Horie S; Nutahara K; Higashihara E
Urology; 2003 Jul; 62(1):182-6. PubMed ID: 12837463
[TBL] [Abstract][Full Text] [Related]
9. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains.
Tamas EF; Epstein JI
Am J Surg Pathol; 2007 Mar; 31(3):390-7. PubMed ID: 17325480
[TBL] [Abstract][Full Text] [Related]
10. Mucin 7 and cytokeratin 20 as new diagnostic urinary markers for bladder tumor.
Retz M; Lehmann J; Amann E; Wullich B; Röder C; Stöckle M
J Urol; 2003 Jan; 169(1):86-9. PubMed ID: 12478110
[TBL] [Abstract][Full Text] [Related]
11. Cytokeratin-20 immunocytology in voided urine exhibits greater sensitivity and reliability than standard cytology in the diagnosis of transitional cell carcinoma of the bladder.
Melissourgos ND; Kastrinakis NG; Skolarikos A; Pappa M; Vassilakis G; Gorgoulis VG; Salla C
Urology; 2005 Sep; 66(3):536-41. PubMed ID: 16140073
[TBL] [Abstract][Full Text] [Related]
12. Detection of micrometastasis by cytokeratin-20 (reverse transcription polymerase chain reaction) in lymph nodes of patients with endometrial cancer.
Fishman A; Klein A; Zemer R; Zimlichman S; Bernheim J; Cohen I; Altaras MM
Gynecol Oncol; 2000 Jun; 77(3):399-404. PubMed ID: 10831349
[TBL] [Abstract][Full Text] [Related]
13. Quantitative detection of cytokeratin 20 mRNA in urine samples as diagnostic tools for bladder cancer by real-time PCR.
Guo B; Luo C; Xun C; Xie J; Wu X; Pu J
Exp Oncol; 2009 Mar; 31(1):43-7. PubMed ID: 19300416
[TBL] [Abstract][Full Text] [Related]
14. Urinary cytokeratin 20 mRNA expression has the potential to predict recurrence in superficial transitional cell carcinoma of the bladder.
Christoph F; Weikert S; Wolff I; Schostak M; Tabiti K; Müller M; Miller K; Schrader M
Cancer Lett; 2007 Jan; 245(1-2):121-6. PubMed ID: 16473461
[TBL] [Abstract][Full Text] [Related]
15. Detection of bladder carcinoma by combined testing of urine for hyaluronidase and cytokeratin 20 RNAs.
Eissa S; Kassim SK; Labib RA; El-Khouly IM; Ghaffer TM; Sadek M; Razek OA; El-Ahmady O
Cancer; 2005 Apr; 103(7):1356-62. PubMed ID: 15717321
[TBL] [Abstract][Full Text] [Related]
16. [Coordinated expression of cytokeratin 7 and 20 in transitional carcinoma of the bladder: diagnostic usefulness].
Cid Mouteira P; Ortíz Rey JA; Antón Badiola I; San Miguel Fraile P; Alvarez Alvarez C; Zungri Telo E; de la Fuente Buceta A
Actas Urol Esp; 2002 Apr; 26(4):279-84. PubMed ID: 12090187
[TBL] [Abstract][Full Text] [Related]
17. Coordinate expression of cytokeratins 7 and 20 in prostate adenocarcinoma and bladder urothelial carcinoma.
Bassily NH; Vallorosi CJ; Akdas G; Montie JE; Rubin MA
Am J Clin Pathol; 2000 Mar; 113(3):383-8. PubMed ID: 10705819
[TBL] [Abstract][Full Text] [Related]
18. A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer.
Bowles L; Bialkowska-Hobrzanska H; Bukala B; Nott L; Razvi H
Can J Urol; 2004 Dec; 11(6):2438-44. PubMed ID: 15636669
[TBL] [Abstract][Full Text] [Related]
19. Immunostaining of cytokeratin 20 in cells from voided urine for detection of bladder cancer.
Golijanin D; Shapiro A; Pode D
J Urol; 2000 Dec; 164(6):1922-5. PubMed ID: 11061882
[TBL] [Abstract][Full Text] [Related]
20. Detection of disseminated urothelial cancer cells in peripheral venous blood by a cytokeratin 20-specific nested reverse transcriptase-polymerase chain reaction.
Fujii Y; Kageyama Y; Kawakami S; Kihara K; Oshima H
Jpn J Cancer Res; 1999 Jul; 90(7):753-7. PubMed ID: 10470288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]